Paradigm Biopharmaceuticals (ASX: PAR) reports durable 26-week canine OA PPS benefits in peer-reviewed PLOS One, bolstering translational human OA potential.

The capacity of super-large models to synthesize responses to sophisticated requests represents a watershed moment in computing.

Kathryn Bigelow’s 2025 gripping political thriller “House of Dynamite” portrays the chaos unleashed when an unidentified nuclear missile strikes the United States, forcing leaders to confront the ...

Paradigm Biopharmaceuticals (ASX: PAR) has completed treatment of its Zilosul injectable pentosan polysulfate (iPPS) drug under the US Food and Drug Administration’s expanded access program, while ...

(OSV News) — Scrolling through his phone, Jamarson Fitzgerald shares shots of a good life: smiling with his three daughters, posing while on the job, a photo of a newspaper clipping from years ago ...

Pfizer has become the first Big Pharma company to sign a pricing deal with the Trump administration Bioxyne has the dope on likely US medical pot reforms Paradigm trial gets a knees-up with its first ...

The program's innovative approach was further highlighted at the recent Future Leaders Deans Forum in Beijing, where deans from 16 institutions convened. The forum culminated in the signing of the ...

BEIJING, Sept. 30, 2025 /PRNewswire/ -- Peking University's Guanghua School of Management welcomed the sixth cohort of its "Future Leaders" International Undergraduate Program this September.